CLINICAL_TRIALS
trial_result
· 2021-04-06
Clinical Trial Update: Afrezza Safety and Pharmacokinetics Study in Pediatric Patients [Phase 2]
Summary
A Phase 2 pediatric safety and pharmacokinetics study of Afrezza has completed, with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mannkind Corporation | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2021-04-06